BEAM-301: Single dose of BEAM-301 administered by IV
BTX-301-001
Phase 2 small_molecule active
Quick answer
BEAM-301: Single dose of BEAM-301 administered by IV for Glycogen Storage Disease Type Ia is a Phase 2 program (small_molecule) at Beam Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Beam Therapeutics
- Indication
- Glycogen Storage Disease Type Ia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active